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Tetherin is a cellular restriction factor that inhibits the release of HIV and other enveloped viruses 
from host cells. A paper from Perez-Caballero et al. (2009) in this issue of Cell clarifies how this 
factor works. The authors show that the aptly named tetherin directly tethers viral particles to the 
plasma membrane.Studies on the interplay between viruses 
and host cells have yielded numerous 
insights into fundamental principles in 
biology, and the examination of spe-
cific aspects of viral replication have 
brought to light unexpected features 
of the virus-host cell conflict. One such 
remarkable clue came to light last year 
through the discovery that the host 
cell protein BST-2/CD317 or “tetherin” 
potently restricts HIV-1 replication by 
preventing the escape of viral particles 
from infected cells. Earlier studies had 
shown that cells either require (restric-
tive cells) or do not require (permissive 
cells) expression of the HIV-1 accessory 
protein Vpu for efficient release of viral 
particles. Neil et al. (2008) then identi-
fied the “restricting” activity as tetherin, 
an interferon-inducible gene product 
that is differentially expressed in restric-
tive cells. Vpu downregulates tetherin 
from the cell surface (Van Damme et al., 
2008), adding weight to the conclusion 
that it was the correct Vpu-responsive 
cellular factor. Since these initial reports 
of the importance of tetherin in restrict-
ing HIV particle release, it has become 
clear that tetherin inhibits the release 
of a variety of enveloped viruses, and 
that viruses have in turn evolved diverse 
strategies to overcome this cellular 
restriction to replication (Le Tortorec 
and Neil, 2009; Zhang et al., 2009). 
Tetherin expression in cells that lack 
baseline expression, such as 293T cells, 
leads to massive accumulation of virion 
particles at the plasma membrane in the 
absence of counteracting factors like 
Vpu. But how does tetherin retain viral 
particles? Does tetherin function as a 
physical tether as implied by the name? 
Or does it act with cellular cofactors in 
an indirect fashion to induce the physi-456 Cell 139, October 30, 2009 ©2009 Elsevcal tethering of particles? In this issue of 
Cell, Perez-Caballero et al. (2009) pro-
vide some answers to these key ques-
tions in HIV biology. As these investi-
gators show, the name tetherin fits the 
molecule’s action like a glove.
Perez-Caballero and colleagues used a 
systematic approach to dissect the func-
tional domains of this unusual protein. 
Tetherin is a type II membrane protein with 
unusual features (Figure 1), including two 
membrane anchors, a transmembrane 
domain near the N terminus, and a glyco-
phosphatidylinositol (GPI)-linked anchor 
at the C terminus. The ectodomain of the 
protein features three cysteine residues 
that may mediate homodimerization, 
two N-linked glycosylation sites, and a 
Figure 1. Tethering Virions to Cells
(A) Tetherin domain structure. The diagram indicates positions of disulfide linkages (C53, C63, and C91), 
glycosylation sites (N65 and N92), and the coiled-coil domains of the wild-type tetherin dimer.
(B) Construction of artificial tetherin. The diagram shows the entirely artificial tetherin molecule that Perez-
Caballero and coworkers (2009) constructed. Artificial tetherin consisted of domains from the transferrin 
receptor (TfR, blue), dystrophia myotonica protein kinase (DMPK, green), and urokinase plasminogen ac-
tivator receptor (uPAR, red). Remarkably, this artificial protein made up of pieced-together “tetherin-like” 
domains recapitulated the ability of tetherin to retain virion particles on the plasma membrane.
(C) Tetherin retains virions on the plasma membrane of infected cells. It requires both the transmembrane 
domain (TM) and glycophosphatidylinositol (GPI) anchor for its function. The figure depicts three poten-
tial tethering configurations consistent with this requirement (Perez-Caballero et al., 2009): an extended 
tetherin dimer with either the transmembrane (left) or GPI anchor (center) in the viral membrane, or both 
membrane anchors in the viral membrane (right).ier Inc.
coiled-coil domain that has yet to be fully 
functionally defined (see Figure 1A). The 
investigators introduced mutations into 
the different domains of tetherin, singly 
and in combination, and then assessed 
the ability of the mutated protein to pre-
vent release of particles from the surface 
of 293T cells. They demonstrate that 
disulfide bonds indeed are required for 
dimerization of tetherin and are necessary 
for potent tethering of viral particles. Elim-
ination of most of the coiled-coil domain 
also diminished tethering, although the 
underlying mechanism is unclear. Impor-
tantly, elimination of either the N-terminal 
transmembrane or the C-terminal GPI 
anchor eliminated the ability of the mol-
ecule to tether virions. The mutagenesis 
work thus suggested that both mem-
brane anchors (transmembrane and GPI) 
and homodimerization are essential for 
tetherin activity, but did not fully address 
the fundamental issue: is tetherin itself a 
physical tether holding viral particles at 
the membrane?
The investigators next took an ele-
gant approach to determine whether 
tetherin acts directly or indirectly. 
They replaced the major domains of 
tetherin—transmembrane, coiled-coil, 
and GPI anchor—with those from three 
unrelated proteins, in each case creat-
ing a functional chimeric protein that 
restricted viral release. In the most 
startling result of the study, Perez-
Caballero and coworkers show that 
an entirely artificial form of tetherin, 
made up solely of domains from three 
proteins that were “tetherin-like” in 
size, topology, and posttranslational 
modifications but shared no sequence 
homology with tetherin inhibited par-
ticle release in a manner remarkably 
similar to tetherin. The similarities of 
the artificial tetherin to the real protein 
extended to scanning electron micros-
copy analysis, where both wild-type 
and artificial tetherin induced large 
accumulations of HIV-1 particles on 
the plasma membrane. Vpu, however, 
was unable to inhibit the activity of the artificial tetherin protein, in agreement 
with previous genetic studies indicat-
ing an important and specific role for 
the tetherin transmembrane domain in 
the interaction with Vpu. The fact that 
an entirely artificial tetherin of unrelated 
sequence can restrict the release of 
virions argues strongly against models 
in which tetherin acts to retain virions 
through cofactor interaction, signaling, 
or other indirect mechanisms.
In a final and convincing set of exper-
iments, the authors demonstrate that 
tetherin does act directly on virions. 
Using both biochemical techniques and 
electron microscopy, they show that 
tetherin is incorporated into viral par-
ticles and argue that incorporation may 
occur through either its GPI anchor or 
its transmembrane domain. Moreover, 
they present evidence that tetherin is 
likely incorporated into virions as a 
disulfide-linked parallel dimer (Figure 
1). Together, their findings argue elo-
quently for a simple model: tetherin is 
a direct physical tether, holding virions 
to the plasma membrane and linking 
virions to each other. In other words, 
Perez-Caballero and colleagues chose 
the name for BST-2/CD317 quite appro-
priately in their previous work; tetherin 
is as tetherin does.
Is the story complete now for teth-
erin? Although this report clearly 
establishes direct physical tethering 
by tetherin, perhaps it is still too early 
to discount completely the influence 
of other cellular factors. A number of 
key questions remain. The function of 
the coiled-coil domains of the tetherin 
dimer remains incompletely defined. 
The coiled-coil motif could, for exam-
ple, interact with other coiled-coil pro-
teins or with additional dimers of teth-
erin, creating more complex oligomers 
that play a role in tethering particles to 
the plasma membrane. Cytoskeletal 
elements may also play a role, as sug-
gested by a recent report showing that 
the proteins RICH2, EBP50, and ezrin 
create a link between tetherin/CD317 Cell 13and the apical actin cytoskeleton (Rol-
lason et al., 2009). Does tetherin and its 
link to both the actin cytoskeleton and 
to lipid rafts (through its GPI anchor) 
help to define the viral particle budding 
site? What cellular factors influence the 
enrichment of tetherin on the budding 
particle, given the known absence of 
a specific interaction with viral struc-
tural proteins? Detailed studies of the 
role of endogenous tetherin in HIV rep-
lication in macrophages, where large 
collections of HIV particles appear 
to assemble in intracellular compart-
ments rather than at the plasma mem-
brane, could reveal additional roles for 
tetherin in HIV biology. Furthermore, 
the mechanism by which Vpu over-
comes the action of tetherin remains 
under considerable debate. Although it 
is too early to say that the entire picture 
has been painted, the new report by 
Perez-Caballero and coworkers offers 
a clear view of tetherin as the direct, 
physical link responsible for retention 
of viral particles at the plasma mem-
brane and provides a unique insight 
into an important innate host defense 
mechanism against attack by patho-
genic viruses.
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